Pharmaceutical Executive September 20, 2024
The latest news for pharma industry insiders.
DPHARM 2024: The Benefit to Adapting Operating Models
DPHARM 2024 carried on with a leadership panel that revolved around “How Pharma is Shifting Operating Models for More Efficient Clinical Trials.” Moderated by Bari Kowal, SVP, development operations, portfolio management & biostatistics data management at Regeneron Pharmaceuticals Inc., she was joined by Deirdre BeVard, SVP, R&D strategic operation at CSL Behring; Candice Fitzgerald, MMedSc, head of CD&O regions at Boehringer Ingelheim; Angela DeLuca, MBA, PMP associate VP, head of global study operations at Amgen; and Staci Hargraves, MBA, VP, innovative health, engagement & advocacy at Johnson & Johnson Innovative Medicine, who expressed that the duty that operating models have—which is to tackle the complexities...
Today's Sponsors
Today's Sponsor